Measurement of the economic impact of visual impairment from age-related macular degeneration in Australia

Hopley, Charles, Carter, Rob and Mitchell, Paul 2003, Measurement of the economic impact of visual impairment from age-related macular degeneration in Australia, Clinical and experimental ophthalmology, vol. 31, no. 6, pp. 522-529, doi: 10.1046/j.1442-9071.2003.00715.x.

Attached Files
Name Description MIMEType Size Downloads

Title Measurement of the economic impact of visual impairment from age-related macular degeneration in Australia
Author(s) Hopley, Charles
Carter, RobORCID iD for Carter, Rob
Mitchell, Paul
Journal name Clinical and experimental ophthalmology
Volume number 31
Issue number 6
Start page 522
End page 529
Publisher Blackwell Science Asia
Place of publication Carlton, Vic.
Publication date 2003
ISSN 1442-6404
Keyword(s) age-related macular degeneration
economic impact
Summary The purpose of this report was to: (i) outline the potential value of health economic studies into age-related macular degeneration (AMD); (ii) provide an overview of health economic studies pertinent to AMD; and (iii) outline the basic frame work of cost-of-illness studies (a useful first step in applying economic methods). The detection and management of sensory loss in the elderly plays a key role in the Australian Government's Healthy Ageing Strategy. Age-related macular degeneration is currently the leading cause of blindness in elderly Australians. Although a large proportion of AMD cases remain untreatable, the introduction of photo­dynamic therapy provides a relatively expensive and possibly cost-effective innovation for others. Antioxidant therapy has also been proven effective in reducing progression of early to late disease. The discipline of economics can contribute to an understanding of AMD prevention and treatment through: (i) describing the current burden of disease; (ii) predicting the changes in the burden of disease over time, and (iii) evaluating the efficiency of different interventions. Cost-of-illness studies have been performed in many fields of medicine. Little work, however, has been done on describing the economic impact from AMD. A number of different economic evaluation methods can be used in judging the efficiency of possible interventions to reduce the disease burden of AMD. Although complementary in nature, each has specific uses and limitations. Studies of the economic impact of eye diseases are both feasible and necessary for informed health care decision-making.
Language eng
DOI 10.1046/j.1442-9071.2003.00715.x
Field of Research 140208 Health Economics
HERDC Research category C1.1 Refereed article in a scholarly journal
Copyright notice ©2003, Royal Australian and New Zealand College of Ophthalmologists
Persistent URL

Document type: Journal Article
Collections: Faculty of Health
School of Health and Social Development
Connect to link resolver
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 11 times in TR Web of Science
Scopus Citation Count Cited 12 times in Scopus
Google Scholar Search Google Scholar
Access Statistics: 884 Abstract Views, 0 File Downloads  -  Detailed Statistics
Created: Mon, 13 Oct 2008, 15:59:49 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact